Guidance

Adrenaline Auto-Injectors (AAIs) safety campaign

Information for patients, healthcare professionals and the wider public to help better understand the importance of AAIs as a potential life-saving medicine.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 24 April 2023
• Last updated: 19 June 2023 — See all updates

Documents

Adrenaline Auto-Injectors (AAIs)

HTML

The correct use of your Adrenaline Auto-Injector (AAI)

PDF, 1.05 MB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Y defnydd cywir o’ch Chwistrellydd Adrenalin Awtomatig (AAI)

PDF, 1.05 MB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

The correct use of your Adrenaline Auto-Injector (AAI) - Polish

PDF, 1.04 MB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

The correct use of your Adrenaline Auto-Injector (AAI) - Punjabi

PDF, 1020 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

The correct use of your Adrenaline Auto-Injector (AAI) - Romanian

PDF, 1.04 MB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

The correct use of your Adrenaline Auto-Injector (AAI) - Urdu

PDF, 1020 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

AAIs (sometimes referred to by their product name i.e., Epipen or JEXT) are licensed medicinal products that deliver adrenaline by means of an auto-injector device for the emergency treatment of anaphylaxis, a life-threatening severe allergic reaction.

Published 24 April 2023
Last updated 19 June 2023 + show all updates

1. 19 June 2023

   Video guidance added, on the use of life saving adrenaline auto-injectors (AAIs).

2. 24 April 2023

   First published.